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Abstract Ageing is an inexorable intrinsic process
that affects all cells, tissues, organs and individuals.
Due to a diminished homeostasis and increased
organism frailty, ageing causes a reduction of the
response to environmental stimuli and, in general, is
associated to an increased predisposition to illness and
death. Actually, it is characterized by a state of reduced
ability to maintain health and general homeodynamics
of the organism. A large part of the ageing phenotype is
explained by an imbalance between inflammatory and
anti-inflammatory networks, which results in the low
grade chronic pro-inflammatory status of ageing,
‘‘inflamm-ageing’’. It is strictly linked to immunose-
nescence, and on the whole they are the major
contributory factors to the increased frequency of
morbidity and mortality among elderly. Inflamm-
ageing is compatible with longevity; even if centenar-
ians have an increased level of inflammatory mediators
in comparison to old subjects and they are very frail,
they also have high level of anti-inflammatory cyto-
kines together with protective genotypes. Actually,
data on case control studies performed in Italian
centenarians suggest that a pro-inflammatory genotype
is unfavourable to reach extreme longevity in good
health and likely favours the onset of age-related
diseases such as cardiovascular diseases and Alzhei-
mer’s disease, the leading causes of mortality and
disability in the elderly. However, many associations
between gene variants and longevity have been found
only in Italian population. This should not be unex-
pected, since ageing and longevity are complex traits
resulting not only and not exclusively from genetics,
but rather from the interactions between genetics,
environment and chance.
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Ageing
Ageing is an inexorable intrinsic process that affects
all cells, tissues, organs and individuals. Due to a
diminished homeostasis and increased organism
frailty, ageing causes a reduction of the response to
environmental stimuli and, in general, is associated to
an increased predisposition to illness and death.
Actually, it is characterized by a state of reduced
ability to maintain health and general homeodynam-
ics of the organism (Troen 2003; Rattan 2008).
Nowadays, many countries have rising ageing
populations and are facing an increased prevalence of
age-related diseases and increasing healthcare costs.
During the twentieth century, life expectancy at birth
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rose by a remarkable 30 years in developed countries,
initially because of reductions in infant, child, and
maternal mortality and then because of declining
mortality in middle and old age. In 1900, about 40%
of babies born in countries for which reliable data
existed were expected to live beyond age 65. Today
in these same countries more than 88% of all
newborns will live past age 65 and at least 44% will
live beyond age 85. However, the rapid rise in elderly
people is accompanied by an increase in the number
of people with chronic age-related diseases since
elderly are less resistant to both environmental and
pathological injury; in addition, they are less resistant
to infection (Olshansky and Ault 1986; Oeppen and
Vaupel 2002).
Why we age is a question answered by evolution-
ary biologists in terms of allocation of resources, and
by gerontologists in terms of damage and repair.
However, the ageing phenotype is a complex inter-
action of stochastic, environmental, genetic and
epigenetic variables. These variables do not create
the ageing phenotype but generate the lack of
molecular fidelity and therefore as the random
accumulation of damage in the human organism’s
cells, tissues, or whole organism during life increases,
the probability of disease and death also augments in
proportion (Troen 2003; Rattan 2008).
As discussed in the present paper, a large part of
the ageing phenotype is explained by an imbalance
between inflammatory and anti-inflammatory net-
works, which results in the low grade chronic pro-
inflammatory status of ageing (Licastro et al. 2005;
Vasto et al. 2007).
Inflammation and ageing
Inflammation is defined as a localized response with
systemic consequences, elicited by trauma or infec-
tion, which helps to destroy, reduce or sequester both
the harmful agent and the wounded tissue. In response
to stable low-grade irritation, inflammation becomes a
chronic condition that continuously damages the
surrounding tissues, and it occurs when the tissues
are unable to overcome the effects of the harmful agent
(Licastro et al. 2005). However, the inflammation
process is not per se a negative phenomenon: it is the
response of the immune system to pathogenic viruses
or bacteria. Throughout evolution, humans have been
set to live approximately 40 or 50 years; however,
today, the immune system has to be active longer than
in the past centuries. This prolonged period of activa-
tion may lead to chronic inflammation, which inexo-
rably damages several/all organs, and this phenotype is
linked to both ageing and chronic diseases (Vasto et al.
2007; Candore et al. 2009, 2010a).
Thus, human ageing can be explained at least in
part by the concept of ‘‘inflamm-ageing’’, i.e. a
combination of inflammation and ageing (Franceschi
et al. 2007). Inflamm-ageing posits that ageing either
physiologically or pathologically can be driven by the
pro-inflammatory cytokines and other inflammatory
mediators produced by the innate immune system.
Animals must maintain homeostasis as they age
despite incessant attack from both intrinsic and
extrinsic stimuli/antigens. These potentially harmful
pro-inflammatory signals at a later stage of life may
act antagonistically to the beneficial role they had in
an earlier stage of life. Accordingly, the concept of
inflamm-ageing is based on an antagonistic pleiot-
ropy theory programmed during evolution (Goto
2008; Cevenini et al. 2010).
In fact, ageing is accompanied by chronic low-
grade inflammation state, showed by a 2 to 4-fold
increase in serum levels of inflammatory mediators
which act as predictors of mortality independent on
pre-existing morbidity. Low grade inflammation has
emerged as critical in the pathogenesis of several age-
related chronic diseases as Alzheimer’s disease (AD),
cardiovascular disease (CVD), type 2 diabetes, sar-
copenia, frailty and functional disability. These
diseases appear to be correlated, leading to the
concept of age-related disease, which may be linked
by the process of inflammation (Candore et al. 2009;
Vasto et al. 2010). So, genes and epigenetic factors
involved in the regulatory pattern of inflammation
should play a role in human ageing (Vasto et al. 2007;
Cevenini et al. 2010). Furthermore high serological
levels of pro-inflammatory mediators like cytokines
and C reactive protein (CRP) seem to be the marker
of unsuccessful ageing (Vasto et al. 2010). In a recent
study blood levels of CRP, interleukin (IL)-6, IL-1
receptor antagonist (IL-1ra) and their combinations,
as predictors of mortality during 4 years, have been
investigated in nonagenarians. Plasma levels of IL-
1ra, IL-6, and CRP were higher in persons who died
during the follow-up than in those who survived.
When sex, education, cardiovascular disease,
566 Biogerontology (2010) 11:565–573
123
diabetes, cancer, history of infections, high density
lipoprotein cholesterol, Mini-Mental State Examina-
tion, body mass index, smoking status, and exercise
were adjusted for, only IL-1ra was a significant
predictor of mortality. Persons in the upper tertiles of
both CRP and IL-1ra, or in the upper tertile of all
three markers, had higher mortality than those who
were not in the upper tertile in any of the markers
(Jylha¨ et al. 2007).
Furthermore, accumulated data strongly suggest
that chronic upregulation of pro-inflammatory genes
and molecules as pro-inflammatory cytokines, i.e. IL-
1b, IL-6, Tumor necrosis Factor (TNF)-a, and cyclo-
oxygenase (COX)-2 are induced during the ageing
process. Moreover, the gene expression of these
inflammatory markers is modulated by the redox-
sensitive transcription factor, NF-kB, which is acti-
vated by the IKK/NIK and MAPK pathways. The
activation of the network of NF-kB-dependent, pro-
inflammatory molecules appears to be the molecular
mechanism underlying numerous age-related diseases
including dementia, cardiovascular disease, cancer,
obesity, metabolic syndrome, and osteoporosis
(Chung et al. 2009).
However, a wide range of different aetiological
factors is likely to contribute to increased low-grade
inflammatory activity in elderly populations including
the contribution of different tissues (adipose tissue,
muscle), organs (brain, liver), immune system and
ecosystems (gut microbiota) (Cevenini et al. 2010).
Furthermore, a recent hypothesis suggests that the
reduction in lifetime exposure to infectious diseases
and other sources of inflammation, the cohort mech-
anism, contributes to the historical decline in old-age
mortality, suggesting long-life pathogen burden as the
most important factor for age-related inflammation.
Accordingly, some studies have linked an individual
exposure to past infection to levels of chronic
inflammation and to increased risk of heart attack,
stroke, and cancer (Finch and Crimmins 2004;
Licastro et al. 2005; Vasto et al. 2007).
On the other hand, persistent peripheral multibac-
teria infection such as periodontitis (PD), associated
with gram-negative anaerobic bacteria capable of
exhibiting localized and systemic infections in the
host, has been proposed as a possible aggravating
cofactor in subjects with vascular disease. In PD the
balance between bacteria and host response is altered,
resulting in a production of high levels of
pro-inflammatory mediators and low levels of anti-
inflammatory ones. Locally, these molecules act in
concert to amplify the inflammatory reaction and
activate the effector mechanisms responsible for tissue
destruction. Moreover, inflammatory chemokines and
cytokines are elevated in plasma of PD patients, thus,
contributing to the systemic inflammatory burden and
exerting potential systemic effects. Data regarding the
PD association with neurodegenerative disorders are
lacking; however, it seems plausible that, during PD,
cytokines increase in AD brain due to stimulation of
trigeminal nerve fibres, or directly from bacterial
products and/or bacteria. It seems relevant that in the
NUN study a relationship between teeth loss and AD
was found, but only in APOe4 negative subjects
(Candore et al. 2009, 2010a, b).
Is ‘‘inflamm-ageing’’ compatible with longevity,
i.e. 100 years of age or more? The answer is positive
and apparently paradoxical, since, even if centenar-
ians have an increased level of inflammatory medi-
ators in comparison to old subjects and they are very
frail, they also have high level of anti-inflammatory
cytokines together with protective genotypes. There-
fore, we think that the most proper approach to tackle
and contain age-related inflammation, ‘‘inflamm-
ageing’’, is not only to identify the more suitable
chemical therapies, but also to better identify the
physiological molecules that are more likely present
in long lived subjects and influence at the same time
different organs of the body with pleiotropic charac-
teristics. Indeed, since inflamm-ageing is a pleiotro-
pic process where many different factors interact, in
the same way pleiotropic interventions acting con-
comitantly on different targets and at different levels
are to be preferred and chosen (Franceschi et al.
2007; Capri et al. 2008; Cevenini et al. 2010).
Immunosenescence
Inflamm-ageing is strictly linked to Immunosenes-
cence, a complex process in which different immu-
nological functions are impaired, others are
remodelled (Candore et al. 2009; Vasto et al. 2010).
Centenarians, a model of ‘‘successful-ageing’’, are a
striking expression of this phenomenon (Franceschi
et al. 1995). It is believed that immunosenescence is a
major contributory factor to the increased frequency
of morbidity and mortality among elderly. It renders
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elderly increasingly susceptible to infectious dis-
eases, to the resurgence of latent infections, and also
to infection by opportunistic organisms. In addition,
there is a decline in the protective effect of vaccina-
tion in the elderly (Grubeck-Loebenstein et al. 2009).
Lifelong and chronic antigenic load results the
major driving force of immunosenescence, which
impacts on lifespan by reducing the number of virgin
antigen-non experienced T cells, and filling the
immunological space with expanded clones of memory
and effector, antigen-experienced T cells. Thus, the
repertoire of cells available to respond to antigenic
challenge from previously unencountered pathogens is
shrinking (Franceschi et al. 2000; De Martinis et al.
2005). Several studies have underlined the importance
of ubiquitous viruses causing chronic latent infections,
such as Herpes Viruses, in determining characteristic
aspects of T-cell branch senescence such as the
progressive exhaustion of naive lymphocytes, the
increase in memory cells and the T repertoire shrink-
age. Particularly, the Herpes virus Cytomegalovirus
(CMV) seropositivity was associated with many of the
same phenotypic and functional alterations of T-cell
immunity considered as biomarkers in ageing. CMV is
the prime driving force behind most of the oligoclonal
expansions and altered phenotypes and functions of
CD8 cells in the elderly. CMV-specific lymphocytes
represent, even in immunocompetent subjects, a siz-
able proportion of both the CD8? and the CD4?
memory compartment and they increase with age.
Furthermore, the accumulation of these cells is due to
the expansion of terminally differentiated exhausted
lymphocytes and expanded clones restricted towards
specific epitopes (Pawelec et al. 2004, 2005, 2009). In
addition, very old subjects with a health status impaired
by the most common age-related diseases exhibit an
increase in CMV-specific effectors T cells, mostly
CD4?, with a parallel increase in anti-CMV IgG
antibodies (Trzonkowski et al. 2003; High 2005). The
increase in cellular specific responses required to cope
with CMV reactivation during ageing produces an
increase in lymphocytes that release pro-inflammatory
cytokines contributing to pro-inflammatory status
involved in several age-related diseases (Trzonkowski
et al. 2003; Vescovini et al. 2007; Sansoni et al. 2008;
Candore et al. 2009; Cevenini et al. 2010).
Even though immune-gerontologists are fascinated
by T cells, the B cell compartment is also affected in
the elderly. In fact the number of B lymphocytes is
decreased in aged humans, the B-cell repertoire is
influenced by ageing during an immune response as
described both in mice and in humans (Szabo et al.
2004); furthermore, it has recently been demonstrated
that the decreased B cell diversity in old age is
correlated with poor health status (Gibson et al. 2009).
Moreover, even if the total serum immunoglobulin
levels don’t change, we have reported an age-related
increase in IgG and IgA levels, and a decrease in IgM
levels and IgD in elderly (Listı` et al. 2006), so
suggesting a shift from the naı¨ve compartment of the
B cell branch towards the memory compartment.
However, the data are controversial as we and others
(Gupta et al. 2005; Colonna-Romano et al. 2008) have
demonstrated a significant decrease in naı¨ve CD27-
B lymphocytes and a not significant reciprocal
increase in CD27? memory B cells, whereas others
(Shi et al. 2005) have shown that CD27? memory B
cells, particularly IgD?IgM?CD27? ‘‘IgM memory
B cells’’, involved in the response to pneumococcal
antigens, decrease dramatically in elderly. In fact, on
the basis of the surface expression of CD27 and IgD B
cells can be divided in (1) IgD?CD27- naı¨ve B cells,
(2) IgD?CD27? memory unswitched cells, and (3)
IgD-CD27? classic memory switched (IgG? or
IgA?) cells (Shi et al. 2003).
In aged we have recently demonstrated that a
double-negative (DN) IgD-CD27- B cell subset is
significantly increased (Colonna-Romano et al. 2008,
2009). Moreover, this DN population although lacks
CD27, has been described as a memory B cell
population, and is expanded in patient with active
lupus and healthy subjects exposed to respiratory
sincitial virus (Wei et al. 2007; Sanz et al. 2008). In
addition in a recent study (Colonna-Romano et al.
2010) we have analyzed B cell subsets in healthy
centenarian offspring (CO) compared to age-matched
controls to see whether any difference exists to
explain the familiar increased lifespan expectancy of
CO. In this population we didn’t observe the typical
na¨ive/memory shift observed in elderly. In particular
we didn’t see the increase of DN (IgD-CD27-) B
cells. This observation suggests that in CO the ability
of bone marrow to generate B cells probably is not
impaired as in elderly or, alternatively, that the
systemic milieu might be different in these ‘‘genet-
ically advantaged’’ people. This is an interesting
hypothesis for two reasons. The first since it is well
known that CO are a good model to study longevity
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(Colonna-Romano et al. 2010); the second one
because it is known that memory and naive B cells
produce different cytokines, as the latter produce the
anti-inflammatory cytokine IL-10 and the former the
pro-inflammatory cytokines TNF. Naive and memory
B cells also express different toll receptors (TLRs)
and so they have a regulatory role in the chronic
infections against viruses and bacteria also producing
cytokines and chemokines. This suggests that the
immune-inflammation is also related to the B cell
branch of the immune system in elderly people since
they are able to produce different chemokines and
cytokines (Chan et al. 1999; Harris et al. 2000; Martin
and Chan 2006). Hence, B cell studies are relevant to
our understanding of instructive immunity, inflam-
mation, genetic background and longevity.
Age-related changes in lymphocytes have been
well studied, whereas findings on the effect of ageing
on phagocytic cell function and redox state are not
consistent in the scientific literature, and there are few
data on centenarians (Franceschi et al. 1995; Di
Lorenzo et al. 1999; Miyaji et al. 2000; Alonso-
Ferna´ndez et al. 2008). On the other hand, several
aspects of the innate immune response are affected by
normal human ageing, resulting in a reduced ability to
provide the immediate response to pathogens and also
to integrate with and influence the acquired immune
response. The mechanisms underlying these changes
include alterations in the activity of a variety of innate
immune cell receptors and their downstream signaling
pathways, as well as changes to the numbers of certain
cells within blood (Panda et al. 2009). This loss of
innate cell function has consequences for immunity
and longevity, with reduced neutrophil and NK cell
activity predictive of increased mortality in old adults
and dysregulation of TLR function affecting vaccine
responsiveness and hyper-responsiveness to viral
infection in aged individuals (Niwa et al. 1989; Di
Lorenzo et al. 1999; Ogata et al. 2001; van Duin et al.
2007; Kong et al. 2008; Panda et al. 2009). In a recent
report, several neutrophil functions (adherence, che-
motaxis, phagocytosis, and stimulated and nonstimu-
lated intracellular superoxide anion levels) and
antioxidant parameters (glutathione levels and cata-
lase activity) were measured in peripheral blood
neutrophil suspension in centenarians, young adults,
and middle-aged adults. Neutrophil functions of the
middle-aged group were worse than those of young
adults and centenarians (lower chemotaxis and
phagocytosis and higher adherence and superoxide
anion levels). The neutrophil functions of the cente-
narians were closer to those of the young adults. This
study found well-preserved antioxidant status in
peripheral blood neutrophils, which are responsible
for initiating the inflammatory cascade. When inflam-
matory processes escape these antioxidant regulatory
mechanisms, systemic effects may be provoked (such
as increasing inflammatory cytokines and other oxi-
dative stress molecules), and these could contribute to
many chronic age-associated diseases and to higher
mortality. The centenarians studied had well-pre-
served antioxidant ability, low superoxide anion
production, and nonaltered peripheral blood neutro-
phil functions. Therefore, these characteristics could
be goals that would enable them to avoid age-
associated diseases and attain longevity. It is possible
that the redox state of neutrophils provides centenar-
ians with better health and prevents age-related
diseases (De la Fuente et al. 2005; Viveros et al.
2007; Alonso-Ferna´ndez et al. 2008).
Genetic background
An impressive and coherent series of epidemiological
data in different populations indicate the presence of a
strong familial component of longevity. These studies
demonstrate that parents, siblings and offspring of
long-lived subjects (but not the spouses of the long-
lived subjects who shared with them most part of their
adult life) have a significant survival advantage, a
higher probability to have been or to became long-
living persons and to have a lower risk to undergo the
most important age-related diseases, such as cardio-
and cerebro-vascular diseases, diabetes and cancer,
when compared to the appropriate control. The
genetics of longevity appears to be quite peculiar,
owing to the fact that it regards the post-reproductive
period of life, a period largely non predicted by
evolution and characterized by a progressive decrease
of the force of selection. Thus, centenarians may have
originated from an initial frail part of the cohort which
was able to survive at younger (reproductive) age and
it was later allowed to exploit genes useful in the post-
reproductive period of life. Vice versa it can be
hypothesized that genes neutral or dangerous at
younger age can became useful at old or extremely
old age (Capri et al. 2008; Franceschi et al. 2008).
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The majority of above described inflammatory
aspects, that characterize ageing, are also detectable in
extreme longevity, where a higher frequency of
genetic markers associated with a reduced pro-
inflammatory ability seems to counteract the onset
of the main age-related inflammatory disorders. The
data on the determinants of human longevity indicate
that centenarians are a good choice for the study of
longevity, because they represent an extreme pheno-
type, i.e., the survival tail of the population who
escaped neonatal mortality, pre-antibiotic era ill-
nesses, and fatal outcomes of age-related complex
diseases. Centenarians are quite capable of mounting
effective inflammatory responses; however, inflam-
matory status, correlated to increasing risk of devel-
oping frailty and diseases, is compensated by the
concomitant development of strong and effective anti-
inflammatory responses. Centenarians are remarkably
enriched in ‘‘good’’ genotypes and show opposite
frequencies of ‘‘bad’’ genotypes in comparison with
patients affected by major age-related pathologies,
such as CVD, AD and cancer (Candore et al. 2006,
2007; Franceschi et al. 2007; Vasto et al. 2008, 2009).
In fact, in the last years investigations aimed to
identify a possible genetic propensity to produce high
or low levels of pro-inflammatory cytokines and other
pro-inflammatory molecules were started. Different
teams of investigators were involved in this ambitious
task. This critical mass allowed to increase the
number of inflammatory cytokine genes found asso-
ciated to longevity (IL-6, TNF-a) as well as those
coding for anti-inflammatory cytokines such as IL-10
and tumor growth factor-b1. In addition genes coding
for molecules crucial for the recognition of pathogens
and the start of immune response such as TLR4 and
other which plays an important role in inflammatory
responses (pyrin, connexin, a1-antitrypsin, 5-lipoxy-
genase, COX-2, chemokine receptor-5) have been
also shown to be associated to longevity (Candore
et al. 2006; Salvioli et al. 2006; Balistreri et al. 2008;
Listı` et al. 2008; Ostan et al. 2008; Rea et al. 2006; Di
Bona et al. 2009; Vasto et al. 2009). On the whole,
these data suggest that a pro-inflammatory genotype
is unfavourable to reach extreme longevity in good
health and likely favours the onset of age-related
diseases such as CVD and AD which are the leading
causes of mortality and disability in the elderly.
Within this perspective, healthy ageing and longevity
are likely the result not only of a lower propensity to
mount inflammatory responses but also of an efficient
anti-inflammatory network, which in unsuccessful
ageing fail to fully neutralize the inflammatory
processes consequent to the lifelong antigenic burden
and exposure to damaging agents. Such a global
imbalance can be a major driving force for frailty and
common age-related pathologies, and should be
addressed and studied within an evolutionary-based
systems biology perspective. Moreover, many asso-
ciations between gene variants and longevity have
been found only in Italian population. This should not
be unexpected, since ageing and longevity are
complex traits resulting not only and not exclusively
from genetics, but rather from the interactions
between genetics, environment and chance (Capri
et al. 2008; Franceschi et al. 2008).
A typical example is represented by IL-6 -174
single nucleotide polymorphism (SNP). Several stud-
ies have assessed changes in frequency of -174 IL-6
SNP with age. If IL-6 tracks with disability and age-
related diseases (Vasto et al. 2010), then there should
be reduction, in the oldest old, of the frequency of
homozygous GG subjects, who produce higher IL-6
levels. However, discordant results have been
obtained. To explore the relationship between this
SNP and longevity, we analyzed individual data on
long-living subjects and controls from eight case–
control studies conducted in Europeans, using meta-
analysis. There was no significant difference in the IL-
6 genotype between the oldest old and controls, but
there was significant between-study heterogeneity. In
a subgroup analyses when male centenarians from the
three Italian studies were included, the frequency of
the IL-6 -174 GG genotype was significantly lower
than the other genotypes, with no evidence of
heterogeneity. Our data supports a negative associa-
tion between the GG genotype of IL-6 SNP and
longevity in Italian centenarians, with males who
carry the genotype being two times less likely to reach
extreme old age compared with subjects carrying CC
or CG genotypes. These findings were not replicated
in other European groups suggesting a possible
interaction between genetics, sex and environment
in reaching longevity (Di Bona et al. 2009).
In this perspective, it is conceivable that longevity
can be achieved by different combinations of these
three components, and thus, when gene pool and
environment change, the combinations leading to
longevity change as well. However, these data
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prompt consideration of the role that antagonistic
pleiotropy plays in diseases and in longevity. Our
immune system has evolved to control pathogens, so
pro-inflammatory responses are likely to be evolu-
tionarily programmed to resist fatal infections. Yet
genetic backgrounds promoting pro-inflammatory
responses play an opposite role in unsuccessful
ageing and in longevity, such that CVD and AD are
a late consequence of evolutionary programming for
a pro-inflammatory response to resist infections at an
early age. Genetic polymorphisms responsible for a
low inflammatory response may better control
inflammatory responses involved in these diseases.
So, these polymorphisms might result in an increased
chance of long life-span in an environment with
reduced pathogen load (Caruso et al. 2005).
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